K Number
K981305
Device Name
OLYMPUS SERUM PROTEIN MULTICALIBRATOR
Date Cleared
1998-05-07

(27 days)

Product Code
Regulation Number
862.1150
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Olympus Serum Protein Multicalibrator is designed for use in Olympus automated clinical chemistry analyzers for IgG, IgA, IgM, C3, C4, Transferrin, Ferritin, CRP, and ASO determinations.
Device Description
Not Found
More Information

Not Found

Not Found

No
The summary describes a calibrator for clinical chemistry analyzers, with no mention of AI or ML in the intended use, device description, or performance studies.

No
The device is a multicalibrator for clinical chemistry analyzers, intended for diagnostic determinations of various proteins, not for treatment or therapy.

Yes
The device is described as a multicalibrator for use in automated clinical chemistry analyzers for the determination of various proteins, which are typically measured for diagnostic purposes.

No

The device is a multicalibrator, which is a physical reagent used with automated clinical chemistry analyzers, not a software-only device.

Yes, based on the provided information, the Olympus Serum Protein Multicalibrator is an IVD (In Vitro Diagnostic) device.

Here's why:

  • Intended Use: The intended use clearly states it's "designed for use in Olympus automated clinical chemistry analyzers for IgG, IgA, IgM, C3, C4, Transferrin, Ferritin, CRP, and ASO determinations." These determinations are performed on biological samples (serum) in vitro (outside the body) to provide information about a patient's health status.
  • Device Type: A calibrator is a substance used to establish the relationship between the signal produced by an analytical instrument and the concentration of the analyte being measured. Calibrators are essential components of many in vitro diagnostic tests.

Therefore, the device fits the definition of an IVD.

N/A

Intended Use / Indications for Use

The Olympus Serum Protein Multicalibrator is designed for use in Olympus automated clinical chemistry analyzers for IgG, IgA, IgM, C3, C4, Transferrin, Ferritin, CRP, and ASO determinations.

Product codes

JIX

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Not Found

Key Metrics

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 862.1150 Calibrator.

(a)
Identification. A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

0

Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services USA. The seal features the department's name in a circular arrangement around the perimeter. In the center is a stylized symbol consisting of three abstract human profiles connected by flowing lines, representing health and human services.

Food and Drug Administration 2098 Gaither Road Rockville MD 20850

7 1998 MAY

Laura Storms-Tyler . Director, Regulatory Affairs Olympus America, Inc. Two Corporate Center Drive Melville, New York 11747

Re : K981305 Olympus Serum Protein Multi Calibrator Regulatory Class: II Product Code: JIX Dated: April 9, 1998 Received: April 10, 1998

Dear Ms. Storms-Tyler:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. ਸ substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

1

Page 2

Under the Clinical Laboratory Improvement Amendments of 1988 onder enc crinical haberauor, a CLIA complexity (Chin 60), chip device may requires, you should contact the Centers for Disease Control and Prevention (CDC) at (770) 488-7655.

This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA acboring of substantial equivalence of your device to a legally marketed predicate device results in a classification for your marroos problems, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,
Steven Litman

Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use Statement

510(k) Number (if known): K981305

Device Name:

Olympus Serum Protein Multi Calibrator

Indications for Use:

The Olympus Serum Protein Multicalibrator is designed for use in Olympus automated clinical chemistry analyzers for IgG, IgA, IgM, C3, C4, Transferrin, Ferritin, CRP, and ASO determinations.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (per 21CFR 801 109)

਼ਸ਼

Over-the Counter Use (Optional Formal 1-2-96)

(Division Sign-Off)
Division of Clinical Laboratory Devices
510(k) Number K981305